Laurie Barclay, MD
NEW YORK (MedscapeWire) Apr 16 More than one-third of patients given brachytherapy for prostate cancer have migration of the radioactive seeds to their lungs, according to a retrospective review in the April issue of Urology.
"A thorough pulmonary workup failed to reveal any short-term harmful side effects; however, long-term follow-up is needed," write Murali K. Ankem, MD, from Robert Wood Johnson Medical School in New Brunswick, New Jersey, and colleagues.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!